Sierra Oncology (SRRA) Myelofibrosis KOL Panel to Highlight Momelotinib Data Presented at ASCO and EHA
|DATE:||June 21, 2021|
|TIME:||12:00 AM EDT|
About The Event
The webinar will feature a presentation by Sierra’s management team to discuss recent data from the previously completed SIMPLIFY-1 and SIMPLIFY-2 studies presented at this year’s European Hematology Association (EHA) and American Society of Clinical Oncology (ASCO) Annual Meetings. Management will be joined by three Key Opinion Leaders (KOLs) – Aaron Gerds, M.D. (Cleveland Clinic), Stephen Oh, M.D., Ph.D. (Washington University School of Medicine), and Srdan Verstovsek, M.D., Ph.D. (MD Anderson Cancer Center) – who will participate in a Q&A panel about the myelofibrosis treatment landscape vis-a-vis this recently released data.